Robert B Bazemore
CIK 1620152 · President & CEO · last filed 2026-05-26
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$834.6K
Companies
7
Total Filings
45
Lifetime Open-Market Net
-$934.5K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NUVB | Director | — | $4.92 | — | $0 | 1 | 2026-05-26 |
| AKTX | Director | 44,642 | $13.40 | $598.2K | $0 | 4 | 2025-12-18 |
| ARDX | Director | 41,551 | $5.69 | $236.4K | $0 | 10 | 2025-06-23 |
| Nuvation Bio Inc. (NUVB.WS) Delisted | Director | 5,000 | $0.01 | $26 | $49.9K | 8 | 2025-05-23 |
| Epizyme, Inc. (EPZM) Delisted | President & CEO | 322,626 | $1.47 | $474.3K | -$984.4K | 16 | 2021-03-29 |
| Neon Therapeutics, Inc. (NTGN) Delisted | Director | — | — | — | $0 | 3 | 2020-05-06 |
| SYNAGEVA BIOPHARMA CORP (GEVA) Delisted | Chief Operating Officer | 0 | — | — | $0 | 3 | 2015-06-23 |
Recent Filings · Page 3 of 5
45 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-02-02 | Epizyme, Inc. (EPZM) Delisted | Grant (A) | +87,500 | $0 | EDGAR |
| 2021-01-27 | Epizyme, Inc. (EPZM) Delisted | Sell (S) | −6,069 | -$69.2K | EDGAR |
| 2020-06-30 | Epizyme, Inc. (EPZM) Delisted | Mixed | +5,727 | -$77.1K | EDGAR |
| 2020-06-22 | Epizyme, Inc. (EPZM) Delisted | Mixed | −10,000 | -$350.2K | EDGAR |
| 2020-06-11 | ARDX | Grant (A) | — | $0 | EDGAR |
| 2020-05-06 | Neon Therapeutics, Inc. (NTGN) Delisted | Disp (D) | — | $0 | EDGAR |
| 2020-03-26 | Epizyme, Inc. (EPZM) Delisted | Mixed | +60,571 | -$50.2K | EDGAR |
| 2020-02-05 | Epizyme, Inc. (EPZM) Delisted | Grant (A) | +52,595 | $0 | EDGAR |
| 2020-01-27 | Epizyme, Inc. (EPZM) Delisted | Mixed | −326 | -$198.1K | EDGAR |
| 2019-06-27 | Neon Therapeutics, Inc. (NTGN) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.